Several possible studies
Story checked
Can blood filtration help with Alzheimers? Initial studies indicate yes. | Biohackr Health (opens in a new tab)
Can blood filtration help with Alzheimers? Initial studies indicate yes. · 2025-07-01
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Can blood filtration help with Alzheimers? Initial studies indicate yes. | Biohackr Health
Can blood filtration help with Alzheimers? Initial studies indicate yes. · 2025-07-01
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Source layer
The 11 papers the story cites
Source study separated from background citations.
The research anchor for the report.
- Cited as backgroundpresented as earlier work
AMBAR, an Encouraging Alzheimer's Trial That Raises Questions.
Frontiers in Neurology · 2020
- Cited as backgroundpresented as earlier work
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer's disease.
Expert Review of Neurotherapeutics · 2021
- Cited as backgroundpresented as earlier work
A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease.
Journal of Neural Transmission (Vienna, Austria : 1996) · 2015
- Cited as backgroundpresented as earlier work
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report.
Neuropsychiatric Disease and Treatment · 2018
- Cited as backgroundpresented as earlier work
Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.
Journal of Alzheimer's Disease : JAD · 2016
- Cited as backgroundpresented as earlier work
Potential therapeutic system for Alzheimer's disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patients.
Journal of Neural Transmission (Vienna, Austria : 1996) · 2012
- Cited as backgroundpresented as earlier work
Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?
Journal of Alzheimer's Disease : JAD · 2016
- Cited as backgroundpresented as earlier work
Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer's disease by whole blood exchange.
Molecular Psychiatry · 2022
- Cited as backgroundpresented as earlier work
Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer's Disease.
Neuropsychiatric Disease and Treatment · 2020
- Cited as backgroundpresented as earlier work
Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer's Disease.
Journal of Clinical Medicine · 2022
- Cited as backgroundpresented as a review
Efficacy and safety of blood derivatives therapy in Alzheimer's disease: a systematic review and meta-analysis.
Systematic Reviews · 2022
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 7Not checkedThe article says studies of blood filtration-related approaches for Alzheimer’s disease are a mix of dialysis, plasmapheresis, and plasma exchange, and that these are not a 1:1 proxy for EBOO/EBO2.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 7Not checkedThe article says the AMBAR trial of plasmapheresis with albumin replacement showed 66% less disease progression based on ADAS-Cog scores and 52% less based on ADCS-ADL scores in pooled treated patients, with the best effect in moderate disease.View evidenceHide evidence
As stated66% less disease progression; 52% less disease progression
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 7Not checkedThe article says hemodialysis studies found lower plasma amyloid-beta levels, which correlated with maintained or improved cognitive function and lower brain amyloid deposition.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 7Not checkedThe article says clearance during a single dialysis session was thought to be 22% for amyloid beta 42 and 35% for amyloid beta 40.View evidenceHide evidence
As stated22% for amyloid beta 42; 35% for amyloid beta 40
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 7Not checkedThe article says animal studies of whole blood exchange showed a 40–80% reduction in brain amyloid plaques and improved spatial memory in mice.View evidenceHide evidence
As stated40–80% reduction in brain amyloid plaques
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 7Not checkedThe article says a systematic review/meta-analysis of plasma exchange found no significant difference in cognitive improvement, but the therapy was safe and well tolerated.View evidenceHide evidence
As statedNo significant difference in cognitive improvement
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 7 of 7Not checkedThe article concludes that blood filtration is "promising but not proven" for dementia, and that if an intervention is safe and may help, the clinic would consider it.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 26 candidate papers
AMBAR, an Encouraging Alzheimer's Trial That Raises Questions.
Frontiers in Neurology · 2020 · PubMed
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer's disease.
Expert Review of Neurotherapeutics · 2021 · PubMed
A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease.
Journal of Neural Transmission (Vienna, Austria : 1996) · 2015 · PubMed
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report.
Neuropsychiatric Disease and Treatment · 2018 · PubMed
Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.
Journal of Alzheimer's Disease : JAD · 2016 · PubMed
And 21 more candidates considered.